Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

M
2017-05-24
BIVVBioverativ Inc.Denner Alexander JDirP - Purchase$55.77+920,0001,080,001+575%+$51,307,437
2017-05-26
RAREUltragenyx Pharmaceutical Inc.Huizenga Theodore AlanVP, Controller, PAOS - Sale$57.46-4809,366-5%-$27,581
AM
2017-05-24
ZSANZosano Pharma CorpWalker John PeterInterim CEOP - Purchase$1.36+73,716206,894+55%+$99,891
2017-05-25
OMEDOncomed Pharmaceuticals IncLasersohn Jack WDirP - Purchase$3.37+34,6141,685,913+2%+$116,639
D
2017-05-24
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$88.38-5,000416,365-1%-$441,900
M
2017-05-24
PBYIPuma Biotechnology, Inc.Adage Capital Partners Gp, L.L.C.10%S - Sale$75.38-1,235,70010,087,636-11%-$93,144,268
2017-05-25
KMPHKempharm, IncCohen Daniel LEVP, Govt., Public RelationsP - Purchase$4.11+2,50020,000+14%+$10,274
D
2017-05-25
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$119.40-1,265658,5810%-$151,039
2017-05-25
REGNRegeneron Pharmaceuticals IncVagelos P RoyCOBS - Sale$458.14-9,295652,018-1%-$4,258,373
2017-05-26
BIVVBioverativ Inc.Paglia Louis JDirP - Purchase$57.76+2,0003,056+189%+$115,520
2017-05-25
BLCMBellicum Pharmaceuticals, IncMusso Alan ACFO, TreasurerS - Sale$12.24-6,31154,908-10%-$77,254
2017-05-25
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+14,00021,000,2490%+$868
M
2017-05-23
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+30,00020,986,2490%+$1,798
2017-05-23
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+29,00020,957,2490%+$1,797
M
2017-05-24
OMEDOncomed Pharmaceuticals IncRoot Jonathan DDirS - Sale$3.71-13,880121,020-10%-$51,441
D
2017-05-25
EPZMEpizyme, Inc.Ho Peter Tai-ChingChief Development OfficerS - Sale+OE$16.11-15,00031,456-32%-$241,664
2017-05-25
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.38+26,000185,887,6560%+$165,786
DM
2017-05-23
PAHCPhibro Animal Health CorpBfi Co., LLC10%S - Sale+OE$34.67-48,00048,000-50%-$1,664,160
DM
2017-05-23
PAHCPhibro Animal Health CorpBendheim JackPres, CEO, 10%S - Sale+OE$34.67-48,00048,000-50%-$1,664,160
M
2017-05-23
NBRVNabriva Therapeutics AGTalbot George HarrisonDirS - Sale$100.56-3253,559-8%-$32,684
2017-05-25
ZSANZosano Pharma CorpErbez GeorgiaCFO, Chief Business OfficerP - Purchase$1.32+68,000115,750+142%+$89,760
M
2017-05-24
ZSANZosano Pharma CorpWalker John PeterInterim CEOP - Purchase$1.36+73,716206,894+55%+$99,891
M
2017-05-24
SUPNSupernus Pharmaceuticals IncBhatt Padmanabh P.SVP of IP, CSOS - Sale$34.90-5,50040,000-12%-$191,950
M
2017-05-24
AGIOAgios Pharmaceuticals IncCantley Lewis Clayton Jr.DirS - Sale$47.09-2,036231,434-1%-$95,885
D
2017-05-23
ALNYAlnylam Pharmaceuticals, Inc.Vaishnaw AkshayEVP, R, DS - Sale+OE$75.00-11,00010,583-51%-$825,000
2017-05-23
OMEDOncomed Pharmaceuticals IncLasersohn Jack WDirP - Purchase$3.55+20,0001,651,299+1%+$71,000
D
2017-05-24
ALKSAlkermes Plc.Pops Richard FDir, CEO, Alkermes plcS - Sale+OE$57.42-25,000630,406-4%-$1,435,535
2017-05-24
RARXRa Pharmaceuticals, Inc.Novartis Bioventures Ltd10%S - Sale$25.01-17,4512,391,952-1%-$436,364
DM
2017-05-23
SCLNSciclone Pharmaceuticals IncBlobel FriedhelmPres, CEOS - Sale+OE$9.32-21,46492,526-19%-$200,130
2017-05-25
CORICorium International, Inc.Perceptive Advisors LLC10%P - Purchase$6.25+1,902,4005,546,129+52%+$11,890,000
2017-05-24
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.42+42,200185,861,6560%+$270,959
2017-05-22
RVNCRevance Therapeutics, Inc.Silvernail Lauren PCFO, CBO, SecretaryS - Sale$20.20-1,79336,566-5%-$36,212
M
2017-05-22
RVNCRevance Therapeutics, Inc.Browne L DanielCEO, PresS - Sale$20.29-32,000164,628-16%-$649,250
D
2017-05-22
GTHXG1 Therapeutics, Inc.Eshelman Ventures, LLC10%P - Purchase$15.00+300,0003,439,151+10%+$4,500,000
D
2017-05-22
GTHXG1 Therapeutics, Inc.Thorp Clay10%P - Purchase$15.00+133,3334,173,729+3%+$1,999,995
D
2017-05-22
GTHXG1 Therapeutics, Inc.Eshelman Fredric NDir, 10%P - Purchase$15.00+300,0003,439,151+10%+$4,500,000
D
2017-05-22
GTHXG1 Therapeutics, Inc.Muir Glenn PDirP - Purchase$15.00+20,000120,969+20%+$300,000
D
2017-05-22
GTHXG1 Therapeutics, Inc.Medimmune Ventures, Inc.10%P - Purchase$15.00+75,0003,484,536+2%+$1,125,000
2017-05-24
BIVVBioverativ Inc.Posner Brian SDirP - Purchase$53.86+2,0005,693+54%+$107,724
D
2017-05-22
GTHXG1 Therapeutics, Inc.Ra Capital Management, LLCFmr 10% Owner See Footnote (2)P - Purchase$15.00+400,0004,968,488+9%+$6,000,000
2017-05-23
PTCTPtc Therapeutics, Inc.Svoronos DawnDirP - Purchase$13.49+25,00025,000New+$337,230
2017-05-22
LOXOLoxo Oncology, Inc.Flaherty Keith T.DirS - Sale$45.09-7,25024,232-23%-$326,936
2017-05-22
ISCOInternational Stem Cell CorpSemechkin AndreyCEO, 10%P - Purchase$1.64+3,2001,581,7840%+$5,248
2017-05-23
GALTGalectin Therapeutics IncZucconi Theodore DanielDirP - Purchase$2.27+1,0001,083>999%+$2,270
M
2017-05-19
ARLZAralez Pharmaceuticals Inc.Aryeh JasonDirS - Sale$1.44-388,68515,000-96%-$558,800
2017-05-19
FOLDAmicus Therapeutics IncDo HungChief Science OfficerS - Sale$8.00-29,914474,438-6%-$239,312
2017-05-19
ABBVAbbvie Inc.Gonzalez Richard ACOB, CEOS - Sale$65.49-71,235284,227-20%-$4,665,063
2017-05-22
INVAInnoviva, Inc.Witek Theodore J. Jr.SVP, Chief Scientific OfficerS - Sale$12.01-7,815244,153-3%-$93,858
2017-05-22
INVAInnoviva, Inc.Desparbes EricSVP, CFOS - Sale$11.85-1,825350,763-1%-$21,626
D
2017-05-22
SCLNSciclone Pharmaceuticals IncBlobel FriedhelmPres, CEOS - Sale+OE$9.44-18,53692,526-17%-$175,026
2017-05-19
CALACalithera Biosciences, Inc.Hecht CurtisSVP, BUS., CORP. DEVELOPMENTS - Sale$16.00-65014,910-4%-$10,400
2017-05-22
CLSDClearside Biomedical, Inc.Shaffer Christy LDirP - Purchase$8.00+1,1003,300+50%+$8,800
2017-05-19
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.25+1,0003,737,2570%+$254
M
2017-05-19
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+23,00020,928,2490%+$1,278
2017-05-19
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.05+28,30020,905,2490%+$1,464
2017-05-19
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$0.63+72,6726,768,448+1%+$45,783
2017-05-22
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.43+120,000185,819,4560%+$772,174
2017-05-19
GLYCGlycomimetics IncThackray Helen M.SVP Clinical Development, CMOS - Sale$12.14-2,000154,615-1%-$24,280
2017-05-19
OMEDOncomed Pharmaceuticals IncRoot Jonathan DDirS - Sale$3.70-7,487134,900-5%-$27,712
M
2017-05-09
IMDZImmune Design Corp.Guthart Leo10%P - Purchase$6.09+30,0003,128,239+1%+$182,607
2017-05-18
RARXRa Pharmaceuticals, Inc.Novartis Bioventures Ltd10%S - Sale$25.50-9,0192,409,4030%-$229,964
D
2017-05-19
AVDLAvadel Pharmaceuticals PlcAnderson Michael SCEOP - Purchase$10.00+2,500225,750+1%+$25,000
DM
2017-05-18
AVDLAvadel Pharmaceuticals PlcStapleton Craig RDirP - Purchase$9.85+31,013613,878+5%+$305,327
D
2017-05-18
AGNAllergan PlcBasgoz NesliDirS - Sale+OE$220.45-1,8896,030-24%-$416,430
2017-05-18
RDUSRadius Health, Inc.Biotech Growth N V10%P - Purchase$34.41+50,0004,958,799+1%+$1,720,345
2017-05-18
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+30,00020,876,9490%+$1,687
D
2017-05-18
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$120.72-1,261657,6690%-$152,225
2017-05-19
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.60+9,200185,699,4560%+$60,685
M
2017-05-17
PAHCPhibro Animal Health CorpBfi Co., LLC10%S - Sale$34.15-48,00023,025-68%-$1,639,200
M
2017-05-17
PAHCPhibro Animal Health CorpBendheim JackPres, CEO, 10%S - Sale$34.15-48,00023,025-68%-$1,639,200
M
2017-05-17
NVLSNivalis Therapeutics, Inc.Bvf Partners L P/il10%P - Purchase$2.30+78,858187,971+72%+$181,319
M
2017-05-18
CLSDClearside Biomedical, Inc.Thorp ClayDir, 10%S - Sale$8.36-24,0003,920,394-1%-$200,610
D
2017-05-18
ALKSAlkermes Plc.Landine Michael JSVP, Corp Dev., Alkermes, Inc.S - Sale+OE$57.23-10,000162,370-6%-$572,254
M
2017-05-17
CLSDClearside Biomedical, Inc.White Daniel H.Pres, CEOS - Sale$8.41-8,000549,309-1%-$67,280
D
2017-05-17
ALKSAlkermes Plc.Pops Richard FDir, CEO, Alkermes plcS - Sale+OE$58.19-50,000630,406-7%-$2,909,439
D
2017-05-18
ABBVAbbvie Inc.Chase William JEVP, CFOS - Sale+OE$65.35-38,300184,044-17%-$2,502,905
2017-05-19
EGRXEagle Pharmaceuticals, Inc.Pernock DavidPres, Chief Comm. OfficerP - Purchase$79.69+255966+36%+$20,321
AD
2017-05-15
FLXNFlexion Therapeutics IncBodick NeilChief Medical OfficerS - Sale+OE$18.95-6,830448,620-1%-$129,448
AD
2017-04-17
FLXNFlexion Therapeutics IncBodick NeilChief Medical OfficerS - Sale+OE$28.23-5,000448,620-1%-$141,132
AD
2017-03-17
FLXNFlexion Therapeutics IncBodick NeilChief Medical OfficerS - Sale+OE$20.41-5,000448,620-1%-$102,039
AD
2017-02-24
FLXNFlexion Therapeutics IncBodick NeilChief Medical OfficerS - Sale+OE$19.15-5,000448,620-1%-$95,758
M
2017-05-17
SELBSelecta Biosciences IncSpringer Timothy ADirP - Purchase$14.00+16,1041,698,708+1%+$225,523
D
2017-05-17
CRMDCormedix Inc.Baluch KhosoCEOP - Purchase$0.47+75,00085,000+750%+$35,625
D
2017-05-17
SNDXSyndax Pharmaceuticals IncOrdentlich PeterChief Scientific OfficerS - Sale+OE$15.00-5,0000-100%-$75,000
2017-05-18
LFVNLifevantage CorpJensen Darren JayCEOP - Purchase$4.34+2,000146,958+1%+$8,680
2017-05-17
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+18,00020,846,9490%+$1,075
D
2017-05-17
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$91.73-5,000416,365-1%-$458,650
2017-05-18
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.59+20,000185,690,2560%+$131,808
2017-05-16
ICPTIntercept Pharmaceuticals IncBright LisaPres InternationalS - Sale$119.74-11323,5000%-$13,531
2017-05-16
NKTRNektar TherapeuticsThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$19.55-2,65152,986-5%-$51,827
2017-05-16
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale$19.55-8,388161,294-5%-$163,985
2017-05-16
NKTRNektar TherapeuticsNicholson JohnSVP, COOS - Sale$19.55-3,146178,943-2%-$61,504
2017-05-16
NKTRNektar TherapeuticsLabrucherie Gil MSVP, CFOS - Sale$19.55-3,17966,091-5%-$62,149
2017-05-16
NKTRNektar TherapeuticsHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$19.55-2,95960,689-5%-$57,848
2017-05-16
NKTRNektar TherapeuticsGergel Ivan P.SVP, Chief Medical OfficerS - Sale$19.55-1,45043,572-3%-$28,348
2017-05-16
NKTRNektar TherapeuticsDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$19.55-1,70132,803-5%-$33,255
2017-05-17
ADROAduro Biotech, Inc.Brockstedt Dirk G.EVP of Research, Dev.S - Sale$9.65-1,01149,300-2%-$9,756
2017-05-17
ADROAduro Biotech, Inc.Templeman BlaineEVP, GCS - Sale$9.65-1,64837,300-4%-$15,903
2017-05-16
OMEDOncomed Pharmaceuticals IncLasersohn Jack WDirP - Purchase$3.49+23,5071,631,299+1%+$82,061
2017-05-16
OMEDOncomed Pharmaceuticals IncRoot Jonathan DDirS - Sale$3.58-6,900142,387-5%-$24,714

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top